세계의 인슐린 펌프 시장 : 규모, 점유율, 동향 분석(유형별, 제품별, 부속품별, 최종 용도별, 지역별), 부문별 예측(2025-2030년)

Insulin Pump Market Growth & Trends:

The global insulin pump market size is estimated to reach USD 9.66 billion by 2030, registering to grow at a CAGR of 8.42% from 2025 to 2030 according to a new report by Grand View Research, Inc. The key factors driving the growth of the market are the technological advancements and the adoption of pumps over traditional methods. These pumps are very convenient for people who require daily multiple injections of insulin.

Insulin pump is a machine that enables insulin to be delivered either manually or automatically. These pumps can be programmed to deliver a specific set of doses and can also deliver a larger set of doses of glucose whenever required, such as before a meal. Patients can connect these devices to their smartphones to calibrate blood glucose readings. Technological advancement and new product launches across the globe are also fueling the market during the forecast period. For instance, Medtronic's MiniMed 670G system is the world's first hybrid closed loop system that acts as an artificial pancreas. The system provides automated insulin delivery as per the patient's CGM readings.

The insulin pumps market is anticipated to witness a high growth rate during the forecast period due to the continuous efforts for diabetes control by government and healthcare organizations such as the International Diabetes Federation (IDF). These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding is anticipated to propel growth. Additionally, the market is expected to witness a shift from the usage of traditional tethered pumps to patch pumps driven by their compact size and ease of use.

Insulin Pump Market Report Highlights:

• The tethered pumps segment dominated the market in 2024 and expected to lead during the forecast period. Tethered insulin pumps are connected to the body via a small tube linked to a cannula.
• The MiniMed segment dominated the market with a share of 52.9% in 2024. the high adoption rate and technological advancement.
• The insulin set insertion devices segment dominated the market with a share of 41.4% in 2024. The insulin set insertion market high share is attributed to notable growth due to advancements in user-friendly designs and enhanced comfort.
• The hospital segment dominated the market with a share of over 44.4 % in 2024. Hospitals are increasingly adopting advanced diabetes management technologies, including insulin pumps, to improve patient outcomes.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Product
  • 1.2.3. Accessories
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type Outlook
  • 2.2.2. Product Outlook
  • 2.2.3. Accessories Outlook
  • 2.2.4. End Use Outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Insulin Pumps Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High prevalence of diabetes and associated disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increasing adoption of insulin pumps
    • 3.2.1.4. Increase in number of product approvals
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High-cost barrier
    • 3.2.2.2. Stringent regulatory approvals
• 3.3. Insulin Pumps Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Insulin Pumps Market: Device Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Insulin Pumps Device Market Movement Analysis
• 4.3. Global Insulin Pumps Market Size & Trend Analysis, by Device, 2018 to 2030 (USD Million)
• 4.4. Patch pumps
  • 4.4.1. Patch pumps market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Tethered pumps
  • 4.5.1. Tethered pumps market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Insulin Pumps Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Insulin Pumps Accessories Market Movement Analysis
• 5.3. Global Insulin Pumps Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. MiniMed
  • 5.4.1. MiniMed market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Accu-Chek
  • 5.5.1. Accu-Chek market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Tandem
  • 5.6.1. Tandem market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Omnipod
  • 5.7.1. Omnipod market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. My life omnipod
  • 5.8.1. My life omnipod market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others
  • 5.9.2. market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Insulin Pumps Market: Accessories Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Insulin Pumps Accessories Market Movement Analysis
• 6.3. Global Insulin Pumps Market Size & Trend Analysis, by Accessories, 2018 to 2030 (USD Million)
• 6.4. Insulin reservoir or cartridges
  • 6.4.1. Insulin reservoir or cartridges market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Insulin set insertion devices
  • 6.5.1. Insulin set insertion devices market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Battery
  • 6.6.1. Battery market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Insulin Pumps Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Insulin Pumps End Use Market Movement Analysis
• 7.3. Global Insulin Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals & Clinics
  • 7.4.1. Hospitals & Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Homecare
  • 7.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Laboratories
  • 7.6.1. Laboratories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Insulin Pumps Market: Regional Estimates & Trend Analysis By Type, Product, Accessories, End Use

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement structure
    • 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement structure
    • 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement structure
    • 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement structure
    • 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement structure
    • 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement structure
    • 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement structure
    • 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement structure
    • 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement structure
    • 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework
    • 8.6.8.4. Reimbursement structure
    • 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement structure
    • 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement structure
    • 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement structure
    • 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement structure
    • 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement structure
    • 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement structure
    • 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement structure
    • 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement structure
    • 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Mexico
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Reimbursement structure
    • 8.8.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement structure
    • 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement structure
    • 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement structure
    • 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement structure
    • 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2024
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. Medtronic
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Device benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Hoffmann-La Roche AG
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Device benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. Tandem Diabetes Care, Inc.
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Device benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Insulet Corporation
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Device benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Ypsomed
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Device benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. Sooil development
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Device benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. Jiangsu Delfu Co., Ltd.
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Device benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. Cellnovo Ltd
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Device benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Valeritas, Inc
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Device benchmarking
    • 9.6.9.4. Strategic initiatives